NCT00865969 2021-10-29
PTCL
Spectrum Pharmaceuticals, Inc
Phase 2 Completed
Clinical Trials
5 trialsNCT00274651 2015-07-28
PXD101-CLN-6
Valerio Therapeutics
Phase 2 Terminated
NCT00421889 2015-07-28
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment
Valerio Therapeutics
Phase 1/2 Completed
NCT00873119 2015-07-28
Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary
Valerio Therapeutics
Phase 2 Completed
NCT00878800 2015-07-28
A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas
Valerio Therapeutics
Phase 1/2 Completed